InfuSystem Holdings, Inc (INFU) stock
INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/304% below fair value
$14.72−0.07 (-0.47%)
Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –
InfuSystem ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
InfuSystem's ebitda for the twelve months ending Sep 30, 2026 was $27.10M, up 12.0% year over year. For fiscal 2025 it was $25.21M, up 30.0% from the year before. The highest annual figure on record is $25.21M in fiscal 2025.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.21M | +30.0% |
| FY2024 | Dec 31, 2024 | $19.39M | +16.8% |
| FY2023 | Dec 31, 2023 | $16.60M | +10.5% |
| FY2022 | Dec 31, 2022 | $15.01M | -13.9% |
| FY2021 | Dec 31, 2021 | $17.45M | -23.7% |
| FY2020 | Dec 31, 2020 | $22.85M | +44.0% |
| FY2019 | Dec 31, 2019 | $15.87M | +35.4% |
| FY2018 | Dec 31, 2018 | $11.72M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $7.87M | +10.9% |
| Q2 FY2026 | Jun 30, 2026 | $7.33M | +2.9% |
| Q1 FY2026 | Mar 31, 2026 | $4.84M | +23.0% |
| Q4 FY2025 | Dec 31, 2025 | $7.06M | +17.0% |
| Q3 FY2025 | Sep 30, 2025 | $7.10M | +10.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.12M | +45.6% |
| Q1 FY2025 | Mar 31, 2025 | $3.94M | +91.6% |
| Q4 FY2024 | Dec 31, 2024 | $6.04M | +37.4% |
| Q3 FY2024 | Sep 30, 2024 | $6.41M | +34.5% |
| Q2 FY2024 | Jun 30, 2024 | $4.89M | +12.6% |
| Q1 FY2024 | Mar 31, 2024 | $2.06M | -33.6% |
| Q4 FY2023 | Dec 31, 2023 | $4.39M | +6.3% |
| Q3 FY2023 | Sep 30, 2023 | $4.77M | +8.7% |
| Q2 FY2023 | Jun 30, 2023 | $4.34M | +20.3% |
| Q1 FY2023 | Mar 31, 2023 | $3.10M | +7.1% |
| Q4 FY2022 | Dec 31, 2022 | $4.13M | -21.4% |
| Q3 FY2022 | Sep 30, 2022 | $4.38M | +29.3% |
| Q2 FY2022 | Jun 30, 2022 | $3.61M | -17.2% |
| Q1 FY2022 | Mar 31, 2022 | $2.89M | -34.9% |
| Q4 FY2021 | Dec 31, 2021 | $5.26M | +15.1% |
| Q3 FY2021 | Sep 30, 2021 | $3.39M | -50.3% |
| Q2 FY2021 | Jun 30, 2021 | $4.36M | -45.8% |
| Q1 FY2021 | Mar 31, 2021 | $4.44M | +29.3% |
| Q4 FY2020 | Dec 31, 2020 | $4.57M | -0.7% |
| Q3 FY2020 | Sep 30, 2020 | $6.81M | +42.2% |
| Q2 FY2020 | Jun 30, 2020 | $8.04M | +101.4% |
| Q1 FY2020 | Mar 31, 2020 | $3.44M | +38.2% |
| Q4 FY2019 | Dec 31, 2019 | $4.60M | – |
| Q3 FY2019 | Sep 30, 2019 | $4.79M | – |
| Q2 FY2019 | Jun 30, 2019 | $3.99M | – |
| Q1 FY2019 | Mar 31, 2019 | $2.49M | – |
See a number that looks wrong?